JP5558104B2 - 心組織の保護および再生のための組成物および方法 - Google Patents

心組織の保護および再生のための組成物および方法 Download PDF

Info

Publication number
JP5558104B2
JP5558104B2 JP2009541336A JP2009541336A JP5558104B2 JP 5558104 B2 JP5558104 B2 JP 5558104B2 JP 2009541336 A JP2009541336 A JP 2009541336A JP 2009541336 A JP2009541336 A JP 2009541336A JP 5558104 B2 JP5558104 B2 JP 5558104B2
Authority
JP
Japan
Prior art keywords
cardiomatrix
cell
composition
self
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009541336A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512393A (ja
JP2010512393A5 (https=
Inventor
リサ スピリオ，
チェン チュー，
Original Assignee
スリー−ディー マトリックス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スリー−ディー マトリックス， インコーポレイテッド filed Critical スリー−ディー マトリックス， インコーポレイテッド
Publication of JP2010512393A publication Critical patent/JP2010512393A/ja
Publication of JP2010512393A5 publication Critical patent/JP2010512393A5/ja
Application granted granted Critical
Publication of JP5558104B2 publication Critical patent/JP5558104B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP2009541336A 2006-12-11 2007-12-11 心組織の保護および再生のための組成物および方法 Expired - Fee Related JP5558104B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86943706P 2006-12-11 2006-12-11
US60/869,437 2006-12-11
PCT/US2007/025271 WO2008073395A2 (en) 2006-12-11 2007-12-11 Compositions and methods for cardiac tissue protection and regeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013097308A Division JP5903068B2 (ja) 2006-12-11 2013-05-07 心組織の保護および再生のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2010512393A JP2010512393A (ja) 2010-04-22
JP2010512393A5 JP2010512393A5 (https=) 2012-01-12
JP5558104B2 true JP5558104B2 (ja) 2014-07-23

Family

ID=39183217

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009541336A Expired - Fee Related JP5558104B2 (ja) 2006-12-11 2007-12-11 心組織の保護および再生のための組成物および方法
JP2013097308A Expired - Fee Related JP5903068B2 (ja) 2006-12-11 2013-05-07 心組織の保護および再生のための組成物および方法
JP2015228381A Withdrawn JP2016033147A (ja) 2006-12-11 2015-11-24 心組織の保護および再生のための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013097308A Expired - Fee Related JP5903068B2 (ja) 2006-12-11 2013-05-07 心組織の保護および再生のための組成物および方法
JP2015228381A Withdrawn JP2016033147A (ja) 2006-12-11 2015-11-24 心組織の保護および再生のための組成物および方法

Country Status (6)

Country Link
US (2) US9012404B2 (https=)
EP (1) EP2089047B1 (https=)
JP (3) JP5558104B2 (https=)
DK (1) DK2089047T3 (https=)
ES (1) ES2400294T3 (https=)
WO (2) WO2008073392A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180085014A (ko) 2015-12-10 2018-07-25 가부시끼가이샤 메니콘 펩티드 조성물

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5255274B2 (ja) * 2004-07-06 2013-08-07 スリーディー マトリックス， インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
JP5497451B2 (ja) * 2007-12-05 2014-05-21 株式会社スリー・ディー・マトリックス 創傷治癒・皮膚再建材
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
AP2011005824A0 (en) * 2009-01-26 2011-08-31 Intermune Inc Methods for treating acute myocardial infarctions and associated disorders.
US20110117195A1 (en) * 2009-11-18 2011-05-19 National Cheng Kung University Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
JP2015021582A (ja) 2013-07-22 2015-02-02 株式会社ジェイテクト 円錐ころ軸受と円錐ころ軸受を用いた動力伝達装置
BR112016019510A2 (pt) 2014-03-10 2017-10-24 3 D Matrix Ltd esterilização e filtração de composições de peptídeos
RU2016139369A (ru) 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
DE102015000363A1 (de) 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用
EP3818071A2 (en) * 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
AU7178301A (en) * 2000-07-06 2002-01-21 American Home Prod Methods for increasing nitric oxide synthase activity
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
PL376213A1 (en) * 2003-01-16 2005-12-27 Boehringer Ingelheim International Gmbh Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
EP2711025A3 (en) * 2003-06-25 2014-09-10 Massachusetts Institute of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
JP4813771B2 (ja) * 2004-04-14 2011-11-09 丸善製薬株式会社 血管内皮型一酸化窒素合成酵素活性促進剤
JP5255274B2 (ja) 2004-07-06 2013-08-07 スリーディー マトリックス， インコーポレイテッド 精製両親媒性ペプチド組成物およびその使用
JP4949661B2 (ja) * 2004-09-21 2012-06-13 第一三共株式会社 ＨＭＧ−ＣｏＡリダクターゼ阻害剤とグルタチオンを含有する医薬組成物
JP2008526749A (ja) * 2005-01-04 2008-07-24 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド 自己アセンブリするペプチドナノファイバーを用いたｐｄｇｆの徐放性の送達
DK1879606T3 (da) * 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180085014A (ko) 2015-12-10 2018-07-25 가부시끼가이샤 메니콘 펩티드 조성물
US10702606B2 (en) 2015-12-10 2020-07-07 Menicon Co., Ltd. Peptide composition

Also Published As

Publication number Publication date
JP2010512393A (ja) 2010-04-22
EP2089047B1 (en) 2012-11-14
JP2013151560A (ja) 2013-08-08
JP2016033147A (ja) 2016-03-10
WO2008073395A3 (en) 2008-11-06
WO2008073392A2 (en) 2008-06-19
WO2008073392A3 (en) 2008-12-18
EP2089047A2 (en) 2009-08-19
ES2400294T3 (es) 2013-04-08
US20150258166A1 (en) 2015-09-17
WO2008073395A2 (en) 2008-06-19
US9012404B2 (en) 2015-04-21
US20100143504A1 (en) 2010-06-10
JP5903068B2 (ja) 2016-04-13
DK2089047T3 (da) 2013-02-18

Similar Documents

Publication Publication Date Title
JP5558104B2 (ja) 心組織の保護および再生のための組成物および方法
US20230190864A1 (en) Purified amphiphilic peptide compositions and uses thereof
Efraim et al. Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction
EP2146733B1 (en) Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20050271631A1 (en) Material compositions and related systems and methods for treating cardiac conditions
WO2017152039A1 (en) Protection and delivery of multiple therapeutic proteins
US20110287068A1 (en) Fibrin and fibrinogen matrices and uses of same
JP5025646B2 (ja) 虚血性心疾患の治療方法
US20230348859A1 (en) Decellularized mammalian extracellular matrix morsels, methods making and methods of using same
WO2021169075A1 (zh) 一种集可注射与抗菌于一体的双功能水凝胶及其制备方法和用途
KR101614802B1 (ko) 심근경색 재생을 위한 세크레토뉴린 펩타이드가 고정된 하이드로젤 및 그 제조방법
KR101110317B1 (ko) 조직재생을 위한 티모신 베타-4 유래 Ａｃ-ＳＤＫＰ 펩타이드의 스마트 방출지지체
EP3389734B1 (en) Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion
CN121648162A (zh) 一种心功能制剂及其制备方法和应用
ES2705602T3 (es) Composiciones de péptidos anfifílicos purificadas y usos de las mismas
KR20240126697A (ko) 조직재생 촉진형 약물전달 조성물 및 이를 포함하는 약물 전달용 키트
Ruvinov et al. Instructive biomaterials for myocardial regeneration and repair
Haoa et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction
Kadner Investigation of synthetic hydrogels as therapy for myocardial infarction
HK1140431B (en) Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
HK1140431A (en) Treatment of leaky or damaged tight junctions and enhancing extracellular matrix

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130507

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140304

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140502

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140521

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140604

R150 Certificate of patent or registration of utility model

Ref document number: 5558104

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees